12 May PATH Meningitis Vaccine Gets $100M
Posted at 15:32h
in News
Luke Timmerman, Seattle PI
The GAVI Alliance, the Geneva, Switzerland-based global health organization, said today it has committed $100 million to support the use of a meningitis vaccine developed by Seattle-based PATH.